A team of researchers has created an innovative drug delivery system with outstanding potential to improve drug development. A team of University of Melbourne researchers from the Caruso ...
A team of University of Melbourne researchers from the Caruso Nanoengineering Group has created an innovative drug delivery system with outstanding potential to improve drug development.
The team has pioneered a drug delivery system that is a coordination network composed of only metal ions and biomolecules, known as metal–biomolecule network (MBN). This system eliminates the ...
A large number of drug carriers have been developed by scientists around the world, but many of these fail due to toxicity from materials that evoke an immune response. "At present, the challenges ...
Nanotechnology is proven to provide certain benefits in drug delivery ... routes of delivery using nanotechnology. Nanoparticle interaction with the coagulation system. Various components of ...
A characterizing feature of nanotechnology is its enabling ... Currently, nanomedicine is dominated by drug delivery systems, accounting for more than 75% of the total sales.
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...
The investigational new drug application for the nanoparticle drug SNB-101 has been cleared for small cell lung cancer ...
Nanotechnology, in particular ... Although additional safety and efficacy testing is needed, these drug delivery systems have the potential to transform how neurological diseases and cancers ...
Nanotechnology could have an enormous impact ... Nanoparticles are well suited for targeted drug delivery, molecular diagnostics and imaging applications (both magnetic resonance imaging (MRI ...
The ability to measure and manipulate substances at the nanomol scale is crucial for various applications in nanotechnology, chemistry, pharmacology, and materials science. Precise quantification at ...